ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the ...

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements. JENA, (Germany), SHANGHAI, (China), | 27 ...

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without ...

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow JENA, Germany and SHANGHAI, Feb. 26, 2025 /PRNewswire/ ...

Food - Allergen - PeanutDistributionAlbertaNew BrunswickNewfoundland and LabradorOntario Sultan Food Products brand Fried Falafel with Tahini Sauce recalled due to undeclared peanut SOURCE Canadian ...

Aligne Wealth Advisors Investment Management (AWAIM) proactively manages risk and return opportunities as markets evolve. This forward-looking approach recently led to strategic portfolio adjustments ...

Despite revenue growth and strategic advancements, Carl Zeiss Meditec AG (CZMWF) faces margin pressures and market uncertainties, particularly in China.

Nevertheless, we were able to post slight growth thanks to the DORC acquisition. The good response to the new products, the approval of our VISUMAX ® 800 refractive laser system for the Chinese market ...

The good response to the new products, the approval of our VISUMAX ® 800 refractive laser system for the Chinese market and the general recovery in order entry and order backlog give us ...

Customers are waiting for the new Kinevo 900S, which became available in the US and Europe in late 2024, and Visumax 800, which was recently approved in China and should be available for purchase ...

Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.

Shares of Carl Zeiss Meditec AG (ETR:AFX) dropped 6% today after the company reported its first-quarter revenues, which showed a slight increase of 1.2% versus the Vara consensus but were coupled with ...